Elicio Therapeutics (ELTX) Prepaid Assets (2020 - 2026)
Elicio Therapeutics (ELTX) reported Prepaid Assets of $1.3 million for Q1 2026, down 34.14% on a YoY basis from $1.9 million in Q1 2025, and up 67.38% quarter-over-quarter from $748000.0 in Q4 2025.
Elicio Therapeutics (ELTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Elicio Therapeutics has reported Prepaid Assets for 7 years, with the latest figure at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 34.14% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 34.14% YoY), and the FY2025 full-year result was $748000.0, down 60.57% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.3 million, up from $748000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $4.5 million in Q2 2023, with the low at $326000.0 in Q3 2022.
- Historically, Prepaid Assets has averaged $2.0 million across 5 years, with a median of $1.9 million in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets soared 948.77% — and 2025, when it sank 82.22%.
- Elicio Therapeutics' Prepaid Assets stood at $2.9 million in 2022, then declined by 6.44% to $2.7 million in 2023, then tumbled by 30.56% to $1.9 million in 2024, then sank by 60.57% to $748000.0 in 2025, then jumped by 67.38% to $1.3 million in 2026.
- The last three Prepaid Assets figures came in at $1.3 million (Q1 2026), $748000.0 (Q4 2025), and $854000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 748,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Jun 30, 2023 | 4.54 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 2.92 Mn |
| Sep 30, 2022 | 326,000.00 |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 498,000.00 |
| Sep 30, 2021 | 549,000.00 |
| Jun 30, 2021 | 538,000.00 |